Medtronic plc (0Y6X.L)
USD 82.93
(-0.31%)
USD 82.93
(-0.31%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 3.67 Billion USD | -2.18% |
| 2022 | 3.75 Billion USD | -25.44% |
| 2021 | 5.04 Billion USD | 39.77% |
| 2020 | 3.6 Billion USD | -24.7% |
| 2019 | 4.78 Billion USD | 3.41% |
| 2018 | 4.63 Billion USD | 49.19% |
| 2017 | 3.1 Billion USD | -22.94% |
| 2016 | 4.02 Billion USD | 13.85% |
| 2015 | 3.53 Billion USD | 32.26% |
| 2014 | 2.67 Billion USD | -12.72% |
| 2013 | 3.06 Billion USD | -11.6% |
| 2012 | 3.46 Billion USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 1.04 Billion USD | 59.33% |
| 2023 Q1 | 791 Million USD | -32.91% |
| 2023 Q2 | 909 Million USD | 14.92% |
| 2023 Q3 | 1.32 Billion USD | 45.43% |
| 2023 Q4 | 654 Million USD | -50.53% |
| 2023 FY | 3.67 Billion USD | -2.18% |
| 2022 Q3 | 1.22 Billion USD | 186.42% |
| 2022 Q4 | 1.17 Billion USD | -3.6% |
| 2022 Q1 | 929 Million USD | -37.48% |
| 2022 Q2 | 427 Million USD | -54.04% |
| 2022 FY | 3.75 Billion USD | -25.44% |
| 2021 Q1 | 763 Million USD | -43.94% |
| 2021 FY | 5.04 Billion USD | 39.77% |
| 2021 Q2 | 1.31 Billion USD | 71.82% |
| 2021 Q3 | 1.47 Billion USD | 12.81% |
| 2021 Q4 | 1.48 Billion USD | 0.47% |
| 2020 Q2 | 489 Million USD | 0.41% |
| 2020 FY | 3.6 Billion USD | -24.7% |
| 2020 Q1 | 487 Million USD | -24.61% |
| 2020 Q3 | 1.27 Billion USD | 159.71% |
| 2020 Q4 | 1.36 Billion USD | 7.17% |
| 2019 Q2 | 1.36 Billion USD | 57.87% |
| 2019 FY | 4.78 Billion USD | 3.41% |
| 2019 Q4 | 646 Million USD | -66.27% |
| 2019 Q3 | 1.91 Billion USD | 40.4% |
| 2019 Q1 | 864 Million USD | -31.7% |
| 2018 Q2 | 1.11 Billion USD | 3.72% |
| 2018 Q4 | 1.26 Billion USD | -0.32% |
| 2018 Q3 | 1.26 Billion USD | 13.81% |
| 2018 Q1 | 1.07 Billion USD | -21.36% |
| 2018 FY | 4.63 Billion USD | 49.19% |
| 2017 Q1 | 1.01 Billion USD | -16.38% |
| 2017 FY | 3.1 Billion USD | -22.94% |
| 2017 Q3 | -1.38 Billion USD | -168.86% |
| 2017 Q4 | 1.36 Billion USD | 198.42% |
| 2017 Q2 | 2.01 Billion USD | 98.52% |
| 2016 Q1 | 929 Million USD | -15.78% |
| 2016 FY | 4.02 Billion USD | 13.85% |
| 2016 Q4 | 1.21 Billion USD | 47.99% |
| 2016 Q3 | 821 Million USD | -26.37% |
| 2016 Q2 | 1.11 Billion USD | 20.02% |
| 2015 Q3 | 1.09 Billion USD | 110.58% |
| 2015 FY | 3.53 Billion USD | 32.26% |
| 2015 Q1 | 820 Million USD | 82100.0% |
| 2015 Q2 | 520 Million USD | -36.59% |
| 2015 Q4 | 1.1 Billion USD | 0.73% |
| 2014 Q2 | 828 Million USD | -4.94% |
| 2014 FY | 2.67 Billion USD | -12.72% |
| 2014 Q4 | -1 Million USD | -100.1% |
| 2014 Q3 | 977 Million USD | 18.0% |
| 2014 Q1 | 871 Million USD | 94.42% |
| 2013 Q4 | 448 Million USD | -41.21% |
| 2013 Q2 | 902 Million USD | -5.35% |
| 2013 Q1 | 953 Million USD | -1.65% |
| 2013 Q3 | 762 Million USD | -15.52% |
| 2013 FY | 3.06 Billion USD | -11.6% |
| 2012 Q4 | 969 Million USD | -1.92% |
| 2012 FY | 3.46 Billion USD | 0.0% |
| 2012 Q3 | 988 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Phreesia, Inc. | -136.88 Million USD | 2785.466% |
| Accuray Incorporated | -15.54 Million USD | 23747.475% |
| Align Technology, Inc. | 445.05 Million USD | -725.969% |
| Elevance Health Inc. | 5.98 Billion USD | 38.6% |
| AxoGen, Inc. | -21.71 Million USD | 17027.611% |
| Boston Scientific Corporation | 1.59 Billion USD | -130.76% |
| CVS Health Corporation | 8.34 Billion USD | 55.944% |
| Cardinal Health, Inc. | 852 Million USD | -331.455% |
| Centene Corporation | 2.7 Billion USD | -36.047% |
| DaVita Inc. | 691.53 Million USD | -431.571% |
| HCA Healthcare, Inc. | 5.24 Billion USD | 29.874% |
| Hologic, Inc. | 789.5 Million USD | -365.611% |
| Humana Inc. | 2.48 Billion USD | -47.69% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | -335.008% |
| Laboratory Corporation of America Holdings | 418 Million USD | -779.426% |
| Masimo Corporation | 81.5 Million USD | -4410.429% |
| McKesson Corporation | 3 Billion USD | -22.452% |
| Patterson Companies, Inc. | 185.93 Million USD | -1877.078% |
| Quest Diagnostics Incorporated | 854 Million USD | -330.445% |
| ResMed Inc. | 1.02 Billion USD | -260.056% |
| Henry Schein, Inc. | 416 Million USD | -783.654% |
| Teladoc Health, Inc. | -220.36 Million USD | 1768.119% |
| Universal Health Services, Inc. | 717.79 Million USD | -412.124% |
| Veeva Systems Inc. | 525.7 Million USD | -599.251% |
| Baxter International Inc. | 2.65 Billion USD | -38.404% |
| Becton, Dickinson and Company | 1.48 Billion USD | -147.709% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | -104.449% |
| Danaher Corporation | 4.2 Billion USD | 12.476% |
| Stryker Corporation | 3.16 Billion USD | -16.145% |